Table 1.
Treatment | Mobile Fraction % | t1/2, h |
---|---|---|
Untreated control (n = 4) | 68.1 ± 5.7 | 1.2 ± 0.19 |
DMSO (n = 4) | 63.4 ± 5.0 | 1.3 ± 0.20 |
Cycloheximide (n = 3) | 62.8 ± 5.2 | 2.1 ± 0.02* |
Fixed (n = 3) | 55.5 ± 5.3 | 3.3 ± 0.35* |
Data are presented as means ± SE. hiPSCs-CMs, human induced pluripotent stem cell-cardiomyocytes.
P < 0.05 vs. control, groups compared by ANOVA.